Jonathan Hunt - 03 Mar 2025 Form 4 Insider Report for Perspective Therapeutics, Inc. (CATX)

Role
Chief Accounting Officer
Signature
/s/ Jonathan Hunt by Chris Nenno, as Attorney-in-Fact
Issuer symbol
CATX
Transactions as of
03 Mar 2025
Net transactions value
$0
Form type
4
Filing time
05 Mar 2025, 16:28:05 UTC
Previous filing
27 Nov 2024
Next filing
17 Nov 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CATX Stock option (right to buy) Award $0 +75,000 $0.000000 75,000 03 Mar 2025 Common Stock 75,000 $2.46 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option grant was approved by the Compensation Committee of the Issuer's Board of Directors on February 13, 2025, with a grant date of March 3, 2025 (the "Grant Date"), and represents the Reporting Person's annual equity award for 2025.
F2 Option vests and becomes exercisable over four years in 48 substantially equal monthly installments beginning on the date that is one month after the Grant Date, subject to the Reporting Person's continued service on each vesting date.